Fulcrum Therapeutics upgraded by Leerink Partners with a new price target
$FULC
Biotechnology: Pharmaceutical Preparations
Health Care
Leerink Partners upgraded Fulcrum Therapeutics from Market Perform to Outperform and set a new price target of $12.00